Global tuberculosis control surveillance, planning, financing : who report 2008

Tuberculosis (TB) is a major cause of illness and death worldwide, especially in Asia and Africa. Globally, 9.2 million new cases and 1.7 million deaths from TB occurred in 2006, of which 0.7 million cases and 0.2 million deaths were in HIV-positive people. Population growth has boosted these numbers compared with those reported by the World Health Organization (WHO) for previous years. More positively, and reinforcing a fi nding fi rst reported in 2007, the number of new cases per capita appears to have been falling globally since 2003, and in all six WHO regions except the European Region where rates are approximately stable. If this trend is sustained, Millennium Development Goal 6, to have halted and begun to reverse the incidence of TB, will be achieved well before the target date of 2015. Four regions are also on track to halve prevalence and death rates by 2015 compared with 1990 levels, in line with targets set by the Stop TB Partnership. Africa and Europe are not on track to reach these targets, following large increases in the incidence of TB during the 1990s. At current rates of progress these regions will prevent the targets being achieved globally. The Stop TB Strategy is WHO's recommended approach to reducing the burden of TB in line with global targets.

Saved in:
Bibliographic Details
Main Authors: Bauquerez, Rachel compilador/a, Bierrenbach, Ana compilador/a
Format: Texto biblioteca
Language:eng
Published: Geneva, Switzerland World Health Organization 2008
Subjects:Financiamiento, Tuberculosis pulmonar, Medicina preventiva, Indicadores de salud,
Online Access:http://data.unaids.org/pub/Report/2008/who2008globaltbreport_en.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!
id KOHA-OAI-ECOSUR:46449
record_format koha
institution ECOSUR
collection Koha
country México
countrycode MX
component Bibliográfico
access En linea
En linea
databasecode cat-ecosur
tag biblioteca
region America del Norte
libraryname Sistema de Información Bibliotecario de ECOSUR (SIBE)
language eng
topic Financiamiento
Tuberculosis pulmonar
Medicina preventiva
Indicadores de salud
Financiamiento
Tuberculosis pulmonar
Medicina preventiva
Indicadores de salud
spellingShingle Financiamiento
Tuberculosis pulmonar
Medicina preventiva
Indicadores de salud
Financiamiento
Tuberculosis pulmonar
Medicina preventiva
Indicadores de salud
Bauquerez, Rachel compilador/a
Bierrenbach, Ana compilador/a
Global tuberculosis control surveillance, planning, financing : who report 2008
description Tuberculosis (TB) is a major cause of illness and death worldwide, especially in Asia and Africa. Globally, 9.2 million new cases and 1.7 million deaths from TB occurred in 2006, of which 0.7 million cases and 0.2 million deaths were in HIV-positive people. Population growth has boosted these numbers compared with those reported by the World Health Organization (WHO) for previous years. More positively, and reinforcing a fi nding fi rst reported in 2007, the number of new cases per capita appears to have been falling globally since 2003, and in all six WHO regions except the European Region where rates are approximately stable. If this trend is sustained, Millennium Development Goal 6, to have halted and begun to reverse the incidence of TB, will be achieved well before the target date of 2015. Four regions are also on track to halve prevalence and death rates by 2015 compared with 1990 levels, in line with targets set by the Stop TB Partnership. Africa and Europe are not on track to reach these targets, following large increases in the incidence of TB during the 1990s. At current rates of progress these regions will prevent the targets being achieved globally. The Stop TB Strategy is WHO's recommended approach to reducing the burden of TB in line with global targets.
format Texto
topic_facet Financiamiento
Tuberculosis pulmonar
Medicina preventiva
Indicadores de salud
author Bauquerez, Rachel compilador/a
Bierrenbach, Ana compilador/a
author_facet Bauquerez, Rachel compilador/a
Bierrenbach, Ana compilador/a
author_sort Bauquerez, Rachel compilador/a
title Global tuberculosis control surveillance, planning, financing : who report 2008
title_short Global tuberculosis control surveillance, planning, financing : who report 2008
title_full Global tuberculosis control surveillance, planning, financing : who report 2008
title_fullStr Global tuberculosis control surveillance, planning, financing : who report 2008
title_full_unstemmed Global tuberculosis control surveillance, planning, financing : who report 2008
title_sort global tuberculosis control surveillance, planning, financing : who report 2008
publisher Geneva, Switzerland World Health Organization
publishDate 2008
url http://data.unaids.org/pub/Report/2008/who2008globaltbreport_en.pdf
work_keys_str_mv AT bauquerezrachelcompiladora globaltuberculosiscontrolsurveillanceplanningfinancingwhoreport2008
AT bierrenbachanacompiladora globaltuberculosiscontrolsurveillanceplanningfinancingwhoreport2008
_version_ 1772402350262059008
spelling KOHA-OAI-ECOSUR:464492023-07-18T11:26:29ZGlobal tuberculosis control surveillance, planning, financing : who report 2008 Bauquerez, Rachel compilador/a Bierrenbach, Ana compilador/a textGeneva, Switzerland World Health Organization2008engTuberculosis (TB) is a major cause of illness and death worldwide, especially in Asia and Africa. Globally, 9.2 million new cases and 1.7 million deaths from TB occurred in 2006, of which 0.7 million cases and 0.2 million deaths were in HIV-positive people. Population growth has boosted these numbers compared with those reported by the World Health Organization (WHO) for previous years. More positively, and reinforcing a fi nding fi rst reported in 2007, the number of new cases per capita appears to have been falling globally since 2003, and in all six WHO regions except the European Region where rates are approximately stable. If this trend is sustained, Millennium Development Goal 6, to have halted and begun to reverse the incidence of TB, will be achieved well before the target date of 2015. Four regions are also on track to halve prevalence and death rates by 2015 compared with 1990 levels, in line with targets set by the Stop TB Partnership. Africa and Europe are not on track to reach these targets, following large increases in the incidence of TB during the 1990s. At current rates of progress these regions will prevent the targets being achieved globally. The Stop TB Strategy is WHO's recommended approach to reducing the burden of TB in line with global targets.The Global Plan of the Stop TB Partnership details the scale at which the six components of the strategy should be implemented if the global targets are to be achieved. To date, progress has been mixed. The fi rst component of the strategy - the detection and treatment of new cases in DOTS programmes - fares best. Globally, the rate of case detection for new smear-positive cases reached 61% in 2006 (compared with the target of at least 70%) and the treatment success rate improved to 84.7% in 2005, just below the target of 85%. Progress in the implementation and planning of other parts of the strategy ranges from major - with provision of TB/HIV interventions for TB patients in the African Region - to minor - with a need for improved guidance on advocacy, communication and social mobilization (ACSM) activities, and more ambitious planning for treatment of patients with multidrugresistant TB (MDR-TB), in the European, South-East Asia and Western Pacifi c regions. Available funding for TB control in 2008 peaked at US$ 3.3 billion across 90 countries (with 91% of global cases) that reported data, up from less than US$ 1 billion in 2002. Nonetheless, these same countries reported funding gaps totalling US$ 385 million in 2008; only fi ve of the 22 high-burden countries reported no funding gap.The gap between the funding reported to be available by countries and the funding requirements estimated to be needed for the same countries in the Global Plan is larger still: US$ 1 billion. This is mainly due to the higher funding requirements for collaborative TB/HIV activities, management of MDR-TB and ACSM in the Global Plan, compared with country report.. Progress in case detection slowed globally in 2006 and began to stall in China and India. The detection rate in the African Region remains low in absolute terms. Budgets stagnated between 2007 and 2008 in all but fi ve of the 22 high-burden countries. Incidence rates are falling slowly compared with the 5-10% decline annually that is theoretically feasible. Renewed effort to accelerate progress in global TB control in line with the expectations of the Global Plan, supported by intensifi ed resource mobilization from domestic and donor sources, is needed.Tuberculosis (TB) is a major cause of illness and death worldwide, especially in Asia and Africa. Globally, 9.2 million new cases and 1.7 million deaths from TB occurred in 2006, of which 0.7 million cases and 0.2 million deaths were in HIV-positive people. Population growth has boosted these numbers compared with those reported by the World Health Organization (WHO) for previous years. More positively, and reinforcing a fi nding fi rst reported in 2007, the number of new cases per capita appears to have been falling globally since 2003, and in all six WHO regions except the European Region where rates are approximately stable. If this trend is sustained, Millennium Development Goal 6, to have halted and begun to reverse the incidence of TB, will be achieved well before the target date of 2015. Four regions are also on track to halve prevalence and death rates by 2015 compared with 1990 levels, in line with targets set by the Stop TB Partnership. Africa and Europe are not on track to reach these targets, following large increases in the incidence of TB during the 1990s. At current rates of progress these regions will prevent the targets being achieved globally. The Stop TB Strategy is WHO's recommended approach to reducing the burden of TB in line with global targets.The Global Plan of the Stop TB Partnership details the scale at which the six components of the strategy should be implemented if the global targets are to be achieved. To date, progress has been mixed. The fi rst component of the strategy - the detection and treatment of new cases in DOTS programmes - fares best. Globally, the rate of case detection for new smear-positive cases reached 61% in 2006 (compared with the target of at least 70%) and the treatment success rate improved to 84.7% in 2005, just below the target of 85%. Progress in the implementation and planning of other parts of the strategy ranges from major - with provision of TB/HIV interventions for TB patients in the African Region - to minor - with a need for improved guidance on advocacy, communication and social mobilization (ACSM) activities, and more ambitious planning for treatment of patients with multidrugresistant TB (MDR-TB), in the European, South-East Asia and Western Pacifi c regions. Available funding for TB control in 2008 peaked at US$ 3.3 billion across 90 countries (with 91% of global cases) that reported data, up from less than US$ 1 billion in 2002. Nonetheless, these same countries reported funding gaps totalling US$ 385 million in 2008; only fi ve of the 22 high-burden countries reported no funding gap.The gap between the funding reported to be available by countries and the funding requirements estimated to be needed for the same countries in the Global Plan is larger still: US$ 1 billion. This is mainly due to the higher funding requirements for collaborative TB/HIV activities, management of MDR-TB and ACSM in the Global Plan, compared with country report.. Progress in case detection slowed globally in 2006 and began to stall in China and India. The detection rate in the African Region remains low in absolute terms. Budgets stagnated between 2007 and 2008 in all but fi ve of the 22 high-burden countries. Incidence rates are falling slowly compared with the 5-10% decline annually that is theoretically feasible. Renewed effort to accelerate progress in global TB control in line with the expectations of the Global Plan, supported by intensifi ed resource mobilization from domestic and donor sources, is needed.Adobe Acrobat profesional 6.0 o superiorFinanciamientoTuberculosis pulmonarMedicina preventivaIndicadores de saludDisponible en líneahttp://data.unaids.org/pub/Report/2008/who2008globaltbreport_en.pdfURN:ISBN:9789241563543Acceso en línea sin restricciones